Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
INDOMETACIN ARENA 50 mg
Non-steroidal anti-inflammatory drug with strong action, indicated in arthritis, gout and rheumatic conditions
Capsules
50 mg
IZONIAZIDA ARENA 100 mg
Essential antituberculosis drug, first-line in the treatment of tuberculosis
Tablets
100 mg
IZONIAZIDA ARENA 300 mg
Essential antituberculosis drug, first-line in the treatment of tuberculosis
Tablets
300 mg
LEFUNOMIDA ARENA 10 mg
Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis
Film-coated tablets
10 mg
LEFUNOMIDA ARENA 100 mg
Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis
Film-coated tablets
100 mg
LEFUNOMIDA ARENA 20 mg
Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis
Film-coated tablets
20 mg
LEVAMISOL ARENA 150 mg
Antiparasitic drug (anthelmintic) with immunomodulatory properties
Tablets
150 mg
LEVAMISOL ARENA 50 mg
Antiparasitic drug (anthelmintic) with immunomodulatory properties
Tablets
50 mg
LEVETIRACETAM ARENA 1000 mg
New-generation anticonvulsant indicated in the treatment of epilepsy
Film-coated tablets
1000 mg